A 3-month lifestyle intervention showed benefit at 5 years in men with low-risk prostate cancer, underscoring for Dr. Kathy Miller the importance of lifestyle in the lives of cancer patients.

New technology reveals that many herbal products on the market contain different ingredients from those listed on their labels, reports Dr. Gerald Chodak.

A new study concludes that screening for prostate cancer "does more harm than good," yet individual patients should be told that they could benefit, says Dr. Gerald Chodak.

FDA Commissioner Margaret Hamburg, MD, talks with Medscape at the National Health Research Forum in Washington, DC.

What we need are affordability endpoints, effective surrogate endpoints, and better information for our clinical colleagues, contend Drs. Stéphane Oudard and Bertrand Tombal at ECC 2013.

Dr. Frank Veith questions the sacred cow of seeking a second opinion for a risky procedure.

A recent study identified common medical practices that offer no net benefit, suggesting that clinicians should tell patients when certain practices are based on opinion rather than evidence.

Dr. Gerald Chodak discusses the impact of insurers' decision to stop paying for costly proton radiotherapy in localized prostate cancer.

Watch this quick review of the key issues affecting girls with Turner syndrome.

What's in a word? Enough to 'set your hair on fire' if the word is cancer, says Dr. George Lundberg, who comments on the importance of not calling a lesion 'cancer' when it is not.